Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
Abstract Background The purpose of the predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC) study is exploratory and hypothesis generating. We want to identify biochemical quantities which—conditionally on the values of available standard demographic, anamnestic, a...
Main Authors: | Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-03-01
|
Series: | Diagnostic and Prognostic Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41512-017-0009-y |
Similar Items
-
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
by: Per Winkel, et al.
Published: (2020-08-01) -
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study
by: Erik Nilsson, et al.
Published: (2020-01-01) -
No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months
by: Forslund Lennart, et al.
Published: (2001-04-01) -
Stable socioeconomic inequalities in ischaemic heart disease mortality during the economic crisis: a time trend analysis in 2 Spanish settings
by: Xavier Bartoll, et al.
Published: (2019-03-01) -
Original paper <br> Adenosine and neutrophil CD11b/CD62L and oxidative burst in stable ischemic heart disease
by: Jacek Rysz, et al.
Published: (2005-09-01)